Avidity Biosciences, Inc. (RNA)

NASDAQ: RNA · Real-Time Price · USD

72.37

+0.12 (0.17%)

At close: Jan 7, 2026, 4:00 PM EST

72.16

-0.21 (-0.29%)

After-hours: Jan 7, 2026, 5:28 PM EST

Avidity Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Jan '26 Jan 7, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Market Capitalization	10,904	3,470	671	1,474	1,115	958	Upgrade
Market Cap Growth	197.71%	417.36%	-54.52%	32.27%	16.40%	-	Upgrade
Enterprise Value	9,079	1,889	139	1,080	703	617	Upgrade
Last Close Price	72.37	29.08	9.05	22.19	23.77	25.52	Upgrade
PS Ratio	522.54	318.39	70.15	159.85	119.53	141.10	Upgrade
PB Ratio	5.63	2.44	1.34	2.55	2.92	3.13	Upgrade
P/TBV Ratio	5.78	2.44	1.34	2.55	2.92	3.13	Upgrade
EV/Sales Ratio	435.05	173.31	14.50	117.11	75.35	90.94	Upgrade
Debt / Equity Ratio	0.03	0.01	0.02	0.02	0.03	0.00	Upgrade
Asset Turnover	0.01	0.01	0.02	0.02	0.02	0.03	Upgrade
Quick Ratio	11.13	15.61	7.49	11.84	13.70	22.58	Upgrade
Current Ratio	11.57	15.74	7.58	12.00	13.86	22.74	Upgrade
Return on Equity (ROE)	-32.44%	-33.47%	-39.34%	-36.27%	-34.32%	-23.62%	Upgrade
Return on Assets (ROA)	-20.28%	-21.60%	-23.24%	-20.97%	-19.38%	-12.85%	Upgrade
Return on Capital (ROIC)	-22.21%	-24.39%	-26.79%	-22.78%	-21.07%	-14.51%	Upgrade
Return on Capital Employed (ROCE)	-31.20%	-25.90%	-43.00%	-30.50%	-29.70%	-13.90%	Upgrade
Earnings Yield	-5.04%	-9.29%	-31.65%	-11.80%	-10.59%	-4.63%	Upgrade
FCF Yield	-5.43%	-8.88%	-18.39%	-9.43%	-8.84%	-3.99%	Upgrade
Buyback Yield / Dilution	-33.44%	-52.83%	-39.97%	-25.91%	-91.24%	-698.49%	Upgrade

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q